Zicam and Orajel
Allegations: Misleadingly marketing products as safe without disclosing that they have been contaminated with fungi that could lead to adverse health consequences
In December 2015, a class-action lawsuit was filed against Zicam for allegedly deceptively marketing Zicam Pre-Cold Medicine products – including RapidMelts, Oral Mist, Ultra Crystals, Lozenges, and Chewables – as having the ability to treat cold symptoms without adequate evidence to support such claims and when scientific evidence shows that the products are “nothing more than a placebo.” (Gulkis et al v. Zicam LLC and Matrixx Initiatives, Inc., Case No. 15-cv-9843, S. D. NY.)
For more information about other class-action lawsuits regarding products claiming to treat cold symptoms and TINA.org’s coverage of them, click here.
Allegations: Misleadingly marketing products as safe without disclosing that they have been contaminated with fungi that could lead to adverse health consequences
Allegations: Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims
Watch out for this company’s sketchy sale.
Some class-action settlements that left consumers out in the cold.
Don’t let this post-trip extension take you for a bumpy ride.
Free offer requires spending money.
The holiday shopping season is here. Tread carefully.